Correction to "Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction"
J Med Chem. 2022 Oct 13;65(19):13482.
doi: 10.1021/acs.jmedchem.2c01533.
Epub 2022 Oct 3.